Inclusion Criteria:

- Women 18 years of age or older,

- Absence of contraindication to laparoscopy,

- Uterine cervical carcinoma (every histological type except neuroendocrine),

- Stage IA1 with lymphatic tumor space involvement (LVSI) or IA2 diagnosed on cervical
conization; or stage IA2, IB1 or IIA detected by clinical examination, confirmed by
biopsy and measured by the MRI, the highest diameter being lower to 4 cm (a
preoperative brachytherapy is allowed for tumors 2 to 4 cm in diameter),

- Negative pregnancy test for women able to procreate,

- Having the French National Social Security

- Signed informed consent

Exclusion Criteria:

- Neuroendocrine carcinoma,

- In situ carcinoma or stage IA1 without LVSI,

- Maximal tumoral diameter measured by MRI more than 4 cm,

- Stage IB1 by "down-staging",

- Stage IB2, IIB to IVB, including those who had a response to neoadjuvant treatment
(chemotherapy or RT + chemotherapy) ,

- Presence of distant metastases,

- Progression of the cervical cancer or recurrence,

- History of pelvic lymphadenectomy,

- Other cancer diagnosed during the course of treatment,

- Contraindication to the injected products : allergy known to Patent Blue or rhenium
sulfide,

- History of severe allergy (history of Quincke's edema, anaphylactic shock),

- Patient who does not understand, speak or write the French language,

- Pregnant woman